Search Results 1321-1330 of 16860 for Fibromyalgia

  1. A Study to Assess the MEK Inhibitor Mirdametinib (PD-0325901) in Patients with Neurofibromatosis Type 1 Associated Plexiform Neurofibromas - Mayo Clinic

    The purpose of this study is to evaluate PD-0325901 in the treatment of symptomatic inoperable neurofibromatosis type-1 (NF1)-associated plexiform neurofibromas ...

  2. Untitled

    Page 1. Page 2. Page 3. Page 4.

  3. Mayo Clinic

    Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic. Give Today · Find a doctor · Explore careers.

  4. Microbiomics Program - Center for Individualized Medicine - Mayo Clinic Research

    What can the microbiome reveal about health? Can microbial communities in the colon be the cause for irritable bowel symptoms? How do gut microbes affect other ...

  5. Untitled

    Page 1. Page 2. Page 3.

  6. Untitled

    Page 1. Page 2. Page 3.

  7. Untitled

    Page 1.

  8. Focus Areas - Mayo Clinic Research

    Mayo Clinic's Device Development and Experimental Therapeutics Lab studies brain machine interfacing, tumor imaging techniques and epilepsy DBS implants.

  9. Movement disorders - Doctors and departments - Mayo Clinic

    Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

  10. Cancer Clinical Trials - Medical Professionals

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...